Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 609
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00617591 | Pegylated Liposomal Doxorubicin, Low Freq Dexamethasone & Revlimid (Dd-R) in Newly Diagnosed Multiple Myeloma (MM) | ||
| NCT05076760 | MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors | ||
| NCT06476548 | Mindfulness-Based Ecological Momentary Intervention For Smoking Cessation Among Cancer Survivors | ||
| NCT06409390 | Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer | ||
| NCT06553885 | Ph II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCC | ||
| NCT01198821 | Gem-TABS in Unresectable Pancreatic Carcinoma | ||
| NCT04879940 | Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization | ||
| NCT00955916 | CLAG Gleevec in Relapsed or Refractory Acute Myeloid Leukemia (AML) | ||
| NCT05048316 | Study to Develop a Group-Based E-Health Intervention for YA Cancer Survivors | ||
| NCT01999985 | Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC) | ||
| NCT00153933 | Bortezomib in Combination With CC-5013 in Patients With Relapsed/Refractory Multiple Myeloma | ||
| NCT05809752 | A First in Human Dose Escalation of Dendritic Cell Vaccine (DCV) | ||
| NCT03906110 | Community Colorectal Cancer Awareness, Research, Education & Screening (C-CARES) | ||
| NCT01776723 | A Sequential Two-Stage Dose Escalation Study to Evaluate the Safety and Efficacy of Ruxolitinib | ||
| NCT06553872 | Phase 2 Open Label Randomized Study of Pirtobrutinib and Brexucabtagene Autoleucel in R/R MCL | ||
| NCT03722407 | Ruxolitinib for the Treatment of Chronic Myelomonocytic Leukemia (CMML): A Phase 2 Expansion | ||
| NCT01008527 | Phase I Oncovir Poly IC:LC and NY-ESO-1/gp100 | ||
| NCT00831766 | Idarubicin + Cytarabine and Lenalidomide in Patients With Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML) | ||
| NCT00496223 | A Phase I/II Study of Sunitinib and Dacarbazine | ||
| NCT05065866 | Duvelisib in Combination With BMS-986345 in Lymphoid Malignancy | ||
| NCT05751941 | Study of Sipuleucel-T With or Without Continuing New Hormonal Agents in Metastatic Prostate Cancer | ||
| NCT01528046 | Metformin in Children With Relapsed or Refractory Solid Tumors | ||
| NCT05316129 | Infusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian Cancer | ||
| NCT06833502 | Phase II Study of Systemic Screening in Pathologic Node Positive Breast Cancer | ||
| NCT00005612 | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer | ||
| NCT04191187 | Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic Malignancies | ||
| NCT04069299 | Use of 68Ga-dotatate PET Scan in Neuroendocrine Carcinoma of the GI Tract | ||
| NCT01176461 | Multiple Class I Peptides & Montanide ISA 51 VG w Escalating Doses of Anti-PD-1 ab BMS936558 | ||
| NCT00738751 | Phase I Study of LBH589 & Erlotinib for Advanced Aerodigestive Tract Cancers | ||
| NCT06350318 | Rituximab and Zanubrutinib in Patients With Indolent B-cell Lymphomas | ||
| NCT05692596 | The Pancreas Interception Center (PIC) for Early Detection, Prevention, and Novel Therapeutics | ||
| NCT02945787 | Spanish-Language Smoking Cessation Trial | ||
| NCT00361140 | Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT) | ||
| NCT03614949 | SBRT and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer | ||
| NCT02509416 | Rapid Assessment of Trainee Endoscopy Skills (RATES) Study Two | ||
| NCT01841021 | Pilot Study of Brentuximab Vedotin in Relapsed/Refractory Peripheral T-Cell Lymphoma Expressing CD30 | ||
| NCT00100906 | Sequential ATRA Then IL-2 for Modulation of Dendritic Cells and Treatment of Metastatic Renal Cell Cancer | ||
| NCT05921552 | Senior Adult Hepatobiliary Prehab Study | ||
| NCT00036686 | Isoflavones in Treating Women Who Have Breast Cancer and Are Planning to Undergo Mastectomy or Lumpectomy | ||
| NCT01681875 | Project 1, Study 1: Investigating the Impact of Nicotine Using Spectrum Cigarettes | ||
| NCT04760847 | Intermittent Fasting for Pancreatitis | ||
| NCT00006033 | Interleukin-2 Gene or Methotrexate in Treating Patients With Recurrent or Refractory Stage III or Stage IV Head and Neck Cancer | ||
| NCT00604461 | Carboplatin, Bevacizumab and Pemetrexed in the First-Line Treatment of Patients With Malignant Pleural Mesothelioma (MPM) | ||
| NCT05645146 | Enhancing Long-Term Smoking Abstinence Among Cervical Cancer Survivors (Project ACCESS) | ||
| NCT04055688 | Novel Exoscope System for 5-ALA Fluorescence-Guided Surgery for Gliomas | ||
| NCT00006092 | Arsenic Trioxide for Induction Therapy of Adult Patients With Leukemia | ||
| NCT01496807 | Yervoy With Sylatron Unresectable Stage 3 or 4 Melanoma | ||
| NCT06104592 | Single-Arm Comprehensive Ablative Bridging Irradiation I Prior to CD19 CAR-T In High-Risk R/R LBCL | ||
| NCT04869137 | Neoadjuvant Lenvatinib Plus Pembrolizumab in Merkel Cell Carcinoma | ||
| NCT04526730 | Neoadjuvant Immunotherapy With Tavo + Electroporation in Combination With Nivo. in Melanoma Patients |
